These data are consistent with previous studies in which protection against Salmonella infection was demonstrated in transgenic mice overexpressing a single human defensin (HD5) or lysozyme21,22, or following treatment of recombinant antimicrobial human β-defensins hBD-1 and hBD-271. The gene discussed is DEFB1; the disease is Salmonella Infections.